(Circulation. 1997;96:3617-3625.)
© 1997 American Heart Association, Inc.
Articles |
From Cardiovascular Research, The Rayne Institute, St Thomas' Hospital, and the Cardiothoracic Department, St Bartholomew's Hospital (S.J.E.), London, UK.
Correspondence to Dr Metin Avkiran, Cardiovascular Research, The Rayne Institute, St Thomas' Hospital, Lambeth Palace Rd, London SE1 7EH, UK. E-mail m.avkiran{at}umds.ac.uk
Background Despite evidence that pharmacological inhibition of the Na+/H+ exchanger (NHE) is cardioprotective, activation of NHE has been proposed as a protective mechanism of ischemic preconditioning (PC).
Methods and Results In isolated rat ventricular myocytes (n=8 to 11 per group) loaded with the fluorescent pH indicator C-SNARF-1, we showed that HOE-642 (HOE) was a potent inhibitor of the sarcolemmal NHE (80% inhibition at 1 µmol/L); such inhibition was readily reversible by washout of the drug. We confirmed that 1 µmol/L HOE produces significant and reversible inhibition of NHE activity in isolated rat hearts as well (n=4), and in this model, we tested (n=8 per group) whether the presence of the drug during (1) the prolonged period of ischemia (40 or 60 minutes) or (2) the preceding brief periods of PC ischemia (3 minutes plus 5 minutes) modulates the protective efficacy of PC. In protocol 1, HOE was infused for 5 minutes immediately before the prolonged ischemic period. With 40 minutes of prolonged ischemia, the postischemic recovery of left ventricular developed pressure (LVDP) was 15±2% in controls and was improved to 45±7% with HOE (P<.05), 55±5% with PC (P<.05), and 68±2% with PC+HOE (P<.05 versus all groups). When the prolonged ischemic period was extended to 60 minutes, an additive effect of PC and HOE was readily apparent and LVDP recovery with PC+HOE (66±2%) was almost double that observed with HOE (37±4%) or PC (34±5%) alone (P<.05). In protocol 2, HOE was infused for 3 minutes immediately before each episode of PC ischemia and was subsequently washed out before a 40-minute prolonged ischemic period (HOE+PC). LVDP recovery was 34±4% in controls and was improved to 57±2% with PC (P<.05) and 55±3% with HOE+PC (P<.05). Improved recovery of LVDP was matched by reduced creatine kinase leakage in all cases.
Conclusions Because coadministration of HOE (at a concentration sufficient to inhibit NHE activity) did not reduce the efficacy of PC in either protocol, we conclude that NHE activity does not contribute to the cardioprotective actions of PC. On the contrary, NHE inhibition during the prolonged ischemic period may enhance the protection afforded by PC.
Key Words: ischemia sodium myocytes
This article has been cited by other articles:
![]() |
J. E. Davies, S. B. Digerness, C. R. Killingsworth, C. Zaragoza, C. R. Katholi, R. K. Justice, S. P. Goldberg, and W. L. Holman Multiple Treatment Approach to Limit Cardiac Ischemia-Reperfusion Injury Ann. Thorac. Surg., October 1, 2005; 80(4): 1408 - 1416. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fujii, M. Avkiran, and D. J Chambers Experimental studies on myocardial protection with intermittent cross-clamp fibrillation: additive effect of the sodium-hydrogen exchanger inhibitor, cariporide Ann. Thorac. Surg., April 1, 2004; 77(4): 1398 - 1407. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Davies, S. B. Digerness, S. P. Goldberg, C. R. Killingsworth, C. R. Katholi, P. S. Brookes, and W. L. Holman Intra-myocyte ion homeostasis during ischemia-reperfusion injury: effects of pharmacologic preconditioning and controlled reperfusion Ann. Thorac. Surg., October 1, 2003; 76(4): 1252 - 1258. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Reffelmann and R. A. Kloner Is microvascular protection by cariporide and ischemic preconditioning causally linked to myocardial salvage? Am J Physiol Heart Circ Physiol, April 1, 2003; 284(4): H1134 - H1141. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. V. Haist, C. N. Hirst, and M. Karmazyn Effective protection by NHE-1 inhibition in ischemic and reperfused heart under preconditioning blockade Am J Physiol Heart Circ Physiol, March 1, 2003; 284(3): H798 - H803. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Mentzer Jr, R. D. Lasley, A. Jessel, and M. Karmazyn Intracellular sodium hydrogen exchange inhibition and clinical myocardial protection Ann. Thorac. Surg., February 1, 2003; 75(2): S700 - 708. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Murashita and K. Yasuda The role of Na+/H+ exchange in the efficacy of multidose hypothermic cardioplegia in immature rabbit hearts Eur. J. Cardiothorac. Surg., December 1, 2002; 22(6): 944 - 950. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Smith Jr, D. Faxon, W. Cascio, H. Schaff, T. Gardner, A. Jacobs, S. Nissen, and R. Stouffer Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group VI: Revascularization in Diabetic Patients Circulation, May 7, 2002; 105 (18): e165 - e169. [Full Text] [PDF] |
||||
![]() |
J. Layland, J.-M. Li, and A. M Shah Role of cyclic GMP-dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes J. Physiol., April 15, 2002; 540(2): 457 - 467. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Avkiran and M. S. Marber Na+/h+ exchange inhibitors for cardioprotective therapy: progress, problems and prospects J. Am. Coll. Cardiol., March 6, 2002; 39(5): 747 - 753. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Toyoda, S. Khan, W. Chen, R. A. Parker, S. Levitsky, and J. D. McCully Effects of NHE-1 inhibition on cardioprotection and impact on protection by K/Mg cardioplegia Ann. Thorac. Surg., September 1, 2001; 72(3): 836 - 843. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Avkiran, G. Gross, M. Karmazyn, H. Klein, E. Murphy, and K. Ytrehus Na+/H+ exchange in ischemia, reperfusion and preconditioning Cardiovasc Res, April 1, 2001; 50(1): 162 - 163. [Full Text] [PDF] |
||||
![]() |
G. T. Altemose, D. P. Zipes, J. Weksler, J. M. Miller, and J. E. Olgin Inhibition of the Na+/H+ Exchanger Delays the Development of Rapid Pacing-Induced Atrial Contractile Dysfunction Circulation, February 6, 2001; 103(5): 762 - 768. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Hale and R. A. Kloner Effect of combined KATP channel activation and Na+/H+ exchange inhibition on infarct size in rabbits Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2673 - H2677. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yokoyama, S. Gunasegaram, S. E. Harding, and M. Avkiran Sarcolemmal Na+/H+ exchanger activity and expression in human ventricular myocardium J. Am. Coll. Cardiol., August 1, 2000; 36(2): 534 - 540. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Theroux Myocardial Cell Protection : A Challenging Time for Action and a Challenging Time for Clinical Research Circulation, June 27, 2000; 101(25): 2874 - 2876. [Full Text] [PDF] |
||||
![]() |
H. Stromer, M. C. H. de Groot, M. Horn, C. Faul, A. Leupold, J. P. Morgan, W. Scholz, and S. Neubauer Na+/H+ Exchange Inhibition With HOE642 Improves Postischemic Recovery due to Attenuation of Ca2+ Overload and Prolonged Acidosis on Reperfusion Circulation, June 13, 2000; 101(23): 2749 - 2755. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Snabaitis, H. Yokoyama, and M. Avkiran Roles of Mitogen-Activated Protein Kinases and Protein Kinase C in {alpha}1A-Adrenoceptor-Mediated Stimulation of the Sarcolemmal Na+-H+ Exchanger Circ. Res., February 4, 2000; 86(2): 214 - 220. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Avkiran Protection of the Myocardium During Ischemia and Reperfusion : Na+/H+ Exchange Inhibition Versus Ischemic Preconditioning Circulation, December 21, 1999; 100(25): 2469 - 2472. [Full Text] [PDF] |
||||
![]() |
R. J. Gumina, E. Buerger, C. Eickmeier, J. Moore, J. Daemmgen, and G. J. Gross Inhibition of the Na+/H+ Exchanger Confers Greater Cardioprotection Against 90 Minutes of Myocardial Ischemia Than Ischemic Preconditioning in Dogs Circulation, December 21, 1999; 100(25): 2519 - 2526. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Haworth, J. Sinnett-Smith, E. Rozengurt, and M. Avkiran Protein kinase D inhibits plasma membrane Na+/H+ exchanger activity Am J Physiol Cell Physiol, December 1, 1999; 277(6): C1202 - C1209. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gunasegaram, R. S. Haworth, D. J. Hearse, and M. Avkiran Regulation of Sarcolemmal Na+/H+ Exchanger Activity by Angiotensin II in Adult Rat Ventricular Myocytes : Opposing Actions via AT1 Versus AT2 Receptors Circ. Res., November 12, 1999; 85(10): 919 - 930. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Karmazyn, X. T. Gan, R. A Humphreys, H. Yoshida, and K. Kusumoto The Myocardial Na+-H+ Exchange : Structure, Regulation, and Its Role in Heart Disease Circ. Res., October 29, 1999; 85(9): 777 - 786. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Humphreys, J. V. Haist, S. Chakrabarti, Q. Feng, J. M. O. Arnold, and M. Karmazyn Orally administered NHE1 inhibitor cariporide reduces acute responses to coronary occlusion and reperfusion Am J Physiol Heart Circ Physiol, February 1, 1999; 276(2): H749 - H757. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yokoyama, M. Yasutake, and M. Avkiran {alpha}1-Adrenergic Stimulation of Sarcolemmal Na+-H+ Exchanger Activity in Rat Ventricular Myocytes : Evidence for Selective Mediation by the {alpha}1A-Adrenoceptor Subtype Circ. Res., June 1, 1998; 82(10): 1078 - 1085. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Layland, J.-M. Li, and A. M Shah Role of cyclic GMP-dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes J. Physiol., April 15, 2002; 540(2): 457 - 467. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Imahashi, T. Nishimura, J. Yoshioka, and H. Kusuoka Role of Intracellular Na+ Kinetics in Preconditioned Rat Heart Circ. Res., June 8, 2001; 88(11): 1176 - 1182. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |